JP2024527142A - リキッドバイオプシーにおける変異検出の方法 - Google Patents
リキッドバイオプシーにおける変異検出の方法 Download PDFInfo
- Publication number
- JP2024527142A JP2024527142A JP2024506585A JP2024506585A JP2024527142A JP 2024527142 A JP2024527142 A JP 2024527142A JP 2024506585 A JP2024506585 A JP 2024506585A JP 2024506585 A JP2024506585 A JP 2024506585A JP 2024527142 A JP2024527142 A JP 2024527142A
- Authority
- JP
- Japan
- Prior art keywords
- dna
- mutation
- group
- fragments
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
- G16B35/20—Screening of libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/204—Modifications characterised by specific length of the oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/122—Massive parallel sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Library & Information Science (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21189685.7 | 2021-08-04 | ||
| EP21189685.7A EP4130293A1 (en) | 2021-08-04 | 2021-08-04 | Method of mutation detection in a liquid biopsy |
| PCT/EP2022/071749 WO2023012186A1 (en) | 2021-08-04 | 2022-08-02 | Method of mutation detection in a liquid biopsy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527142A true JP2024527142A (ja) | 2024-07-19 |
| JP2024527142A5 JP2024527142A5 (cg-RX-API-DMAC7.html) | 2025-08-06 |
Family
ID=77226600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506585A Pending JP2024527142A (ja) | 2021-08-04 | 2022-08-02 | リキッドバイオプシーにおける変異検出の方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240327924A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4130293A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024527142A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023012186A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120048346B (zh) * | 2025-01-24 | 2026-02-27 | 中科金辰生物科技(合肥)有限公司 | 一种肿瘤特异性基因突变和甲基化联合生物信息学分析方法及系统 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11342047B2 (en) * | 2017-04-21 | 2022-05-24 | Illumina, Inc. | Using cell-free DNA fragment size to detect tumor-associated variant |
| GB201819134D0 (en) * | 2018-11-23 | 2019-01-09 | Cancer Research Tech Ltd | Improvements in variant detection |
| GB201818159D0 (en) | 2018-11-07 | 2018-12-19 | Cancer Research Tech Ltd | Enhanced detection of target dna by fragment size analysis |
| WO2020186024A1 (en) * | 2019-03-13 | 2020-09-17 | Grail, Inc. | Systems and methods for enriching for cancer-derived fragments using fragment size |
-
2021
- 2021-08-04 EP EP21189685.7A patent/EP4130293A1/en not_active Withdrawn
-
2022
- 2022-08-02 US US18/293,951 patent/US20240327924A1/en active Pending
- 2022-08-02 EP EP22758542.9A patent/EP4381092A1/en active Pending
- 2022-08-02 WO PCT/EP2022/071749 patent/WO2023012186A1/en not_active Ceased
- 2022-08-02 JP JP2024506585A patent/JP2024527142A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4130293A1 (en) | 2023-02-08 |
| EP4381092A1 (en) | 2024-06-12 |
| WO2023012186A1 (en) | 2023-02-09 |
| US20240327924A1 (en) | 2024-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12191000B2 (en) | Systems and methods for classifying patients with respect to multiple cancer classes | |
| TWI874039B (zh) | 利用核酸長度範圍於非侵入性產前檢測及癌症偵測 | |
| US20190292607A1 (en) | Using test patterns of chromosomal regions in plasma dna for detecting cancer | |
| US20210104297A1 (en) | Systems and methods for determining tumor fraction in cell-free nucleic acid | |
| EP3801623A1 (en) | Convolutional neural network systems and methods for data classification | |
| US20200219587A1 (en) | Systems and methods for using fragment lengths as a predictor of cancer | |
| US20210065842A1 (en) | Systems and methods for determining tumor fraction | |
| US20200385813A1 (en) | Systems and methods for estimating cell source fractions using methylation information | |
| CN112086129A (zh) | 预测肿瘤组织cfDNA的方法及系统 | |
| KR20190085667A (ko) | 무세포 dna를 포함하는 샘플에서 순환 종양 dna를 검출하는 방법 및 그 용도 | |
| JP2024545610A (ja) | 疾患分類のための長い無細胞dna分子を用いた分子分析 | |
| CN113544288A (zh) | 用于预测肝癌复发的dna甲基化标志物及其用途 | |
| JP2024527142A (ja) | リキッドバイオプシーにおける変異検出の方法 | |
| JP2026509730A (ja) | 白血球混入検出 | |
| WO2025061097A1 (en) | Uses of cell-free dna fragmentation patterns associated with epigenetic modifications | |
| US20250079005A1 (en) | Eccdna remnants as a cancer biomarker | |
| TW202609789A (zh) | 衰老之片段化模式 | |
| Ensminger | Early Cancer Detection in Hereditary Breast and Ovarian Cancer Syndrome with Cell-Free DNA | |
| HK40004786A (en) | A ctdna-based gene detection device, storage medium and computer system | |
| HK40004786B (en) | A ctdna-based gene detection device, storage medium and computer system | |
| CN111094594A (zh) | 产生复数候选探针和鉴定哺乳动物中细胞类型的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250729 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250729 |